Theradiag SA (ALTHE) - Total Liabilities

Latest as of June 2025: €14.09 Million EUR ≈ $16.47 Million USD

Based on the latest financial reports, Theradiag SA (ALTHE) has total liabilities worth €14.09 Million EUR (≈ $16.47 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Theradiag SA - Total Liabilities Trend (2001–2024)

This chart illustrates how Theradiag SA's total liabilities have evolved over time, based on quarterly financial data. See Theradiag SA working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Theradiag SA Competitors by Total Liabilities

The table below lists competitors of Theradiag SA ranked by their total liabilities.

Company	Country	Total Liabilities
Cyclone Metals Ltd AU:CLE	Australia	AU$1.18 Million
SBF AG F:CY1K	Germany	€17.86 Million
TREJHARA SOLUTIONS LIMITED NSE:TREJHARA	India	Rs981.24 Million
Veru Inc NASDAQ:VERU	USA	$10.44 Million
Dedicare AB (publ) ST:DEDI	Sweden	Skr285.40 Million
Atlantaa Limited NSE:ATLANTAA	India	Rs3.52 Billion
Li Kang Biomedical Co Ltd TWO:6242	Taiwan	NT$221.82 Million
Farm Price Holdings Berhad KLSE:0304	Malaysia	RM19.85 Million

Liability Composition Analysis (2001–2024)

This chart breaks down Theradiag SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Theradiag SA stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.40	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-5.55	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	1.22	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Theradiag SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Theradiag SA (2001–2024)

The table below shows the annual total liabilities of Theradiag SA from 2001 to 2024.

Year	Total Liabilities	Change
2024-12-31	€11.47 Million ≈ $13.41 Million	-11.86%
2023-12-31	€13.01 Million ≈ $15.21 Million	-2.90%
2022-12-31	€13.40 Million ≈ $15.66 Million	+2.26%
2021-12-31	€13.10 Million ≈ $15.32 Million	-4.95%
2020-12-31	€13.78 Million ≈ $16.12 Million	+30.13%
2019-12-31	€10.59 Million ≈ $12.38 Million	+4.91%
2018-12-31	€10.10 Million ≈ $11.80 Million	-1.96%
2017-12-31	€10.30 Million ≈ $12.04 Million	+12.77%
2016-12-31	€9.13 Million ≈ $10.68 Million	+7.44%
2015-12-31	€8.50 Million ≈ $9.94 Million	+54.25%
2014-12-31	€5.51 Million ≈ $6.44 Million	-18.33%
2013-12-31	€6.75 Million ≈ $7.89 Million	+132.77%
2012-12-31	€2.90 Million ≈ $3.39 Million	+32.55%
2011-12-31	€2.19 Million ≈ $2.56 Million	-16.97%
2010-12-31	€2.63 Million ≈ $3.08 Million	-28.70%
2009-12-31	€3.69 Million ≈ $4.32 Million	+354.93%
2001-12-31	€812.00K ≈ $949.31K	--

About Theradiag SA

PA:ALTHE France Medical Devices

Market Cap

$48.35 Million

€41.36 Million EUR

Market Cap Rank

#23058 Global

#365 in France

Share Price

€0.70

Change (1 day)

-6.67%

52-Week Range

€0.31 - €0.87

All Time High

€8.20